Prostate Cancer Reports
54

Volume 5 Supplement 2
February 2017



Home > Prostate Cancer Reports > Volume 5, Year 2017 > Supplement 2, Febuary


CONTENTS



DIAGNOSIS AND EVALUATION
OVERALL MANAGEMENT
PROGNOSIS AND OUTCOMES
TREATMENT





DIAGNOSIS AND EVALUATION



Nam RK, Wallis CJ, Stojcic-Bendavid J, Milot L, Sherman C, Sugar L, Haider MA.
A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population.
J Urol. 2016 Aug;196(2):361-6. doi: 10.1016/j.juro.2016.01.114. Epub 2016 Feb 13.
Comment in: Jones TA, Marks LS, Re: A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population. [Eur Urol. 2017 Feb 20]
Source | Abstract | Full text | Similar articles





OVERALL MANAGEMENT



Klotz L (ed).
Active Surveillance for Localized Prostate Cancer: A New Paradigm for Clinical Management.
Humana Press, 2012
Source | Abstract | Full text





PROGNOSIS AND OUTCOMES



Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Blute ML.
Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy.
J Urol. 2008 Apr;179(4):1354-60; discussion 1360-1. doi: 10.1016/j.juro.2007.11.061. Epub 2008 Mar 4.
Source | Abstract | Full text | Similar articles




Cooperberg MR, Broering JM, Carroll PR.
Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis.
J Natl Cancer Inst. 2009 Jun 16;101(12):878-87. doi: 10.1093/jnci/djp122. Epub 2009 Jun 9.
Source | Abstract | Full text | Similar articles




D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A.
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.
JAMA. 1998 Sep 16;280(11):969-74.
Source | Abstract | Full text | Similar articles




Cooperberg MR.
Prostate cancer risk assessment: choosing the sharpest tool in the shed.
Cancer. 2008 Dec 1;113(11):3062-6. doi: 10.1002/cncr.23920.
Comment on: Shariat SF, Karakiewicz PI, et al.: An updated catalog of prostate cancer predictive tools. [Cancer, 2008 Dec 1]
Source | Abstract | Full text | Similar articles




Cooperberg MR, Freedland SJ, Pasta DJ, Elkin EP, Presti JC Jr, Amling CL, Terris MK, Aronson WJ, Kane CJ, Carroll PR.
Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy.
Cancer. 2006 Nov 15;107(10):2384-91. Epub 2006 Oct 12.
Source | Abstract | Full text | Similar articles




Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, Carroll PR.
The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy.
Comment in: Nelson JB, Eliminating the current Bell curve to improve the results of radical prostatectomy. (J Urol. 2005 Jun;173(6):1848-9.)
J Urol. 2005 Jun;173(6):1938-42.
Erratum in: J Urol. 2006 Jun;175(6):2369.
Source | Abstract | Full text | Similar articles




Gabriele D, Jereczek-Fossa BA, Krengli M, Garibaldi E, Tessa M, Moro G, Girelli G, Gabriele P; EUREKA-2 consortium
Beyond D'Amico risk classes for predicting recurrence after external beam radiotherapy for prostate cancer: the Candiolo classifier.
Radiat Oncol. 2016 Feb 24;11:23. doi: 10.1186/s13014-016-0599-5.
Source | Abstract | Full text | Similar articles




Hernandez DJ, Nielsen ME, Han M, Partin AW.
Contemporary evaluation of the D'amico risk classification of prostate cancer.
Urology. 2007 Nov;70(5):931-5.
Source | Abstract | Full text | Similar articles




May M, Knoll N, Siegsmund M, Fahlenkamp D, Vogler H, Hoschke B, Gralla O.
Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
J Urol. 2007 Nov;178(5):1957-62; discussion 1962. Epub 2007 Sep 17.
Source | Abstract | Full text | Similar articles




Moul JW.
The evolving definition of advanced prostate cancer.
Rev Urol. 2004;6 Suppl 8:S10-7.
Source | Abstract | Full text | Similar articles




Nelson JB.
Eliminating the current Bell curve to improve the results of radical prostatectomy.
J Urol. 2005 Jun;173(6):1848-9.
Comment on: Cooperberg MR et al., The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. (J Urol. 2005 Jun;173(6):1938-42).
Source | Abstract | Full text | Similar articles




Rodrigues G, Warde P, Pickles T, Crook J, Brundage M, Souhami L, Lukka H; Genitourinary Radiation Oncologists of Canada
Pre-treatment risk stratification of prostate cancer patients: A critical review.
Can Urol Assoc J. 2012 Apr;6(2):121-7. doi: 10.5489/cuaj.11085.
Source | Abstract | Full text | Similar articles




Shariat SF, Karakiewicz PI, Roehrborn CG, Kattan MW.
An updated catalog of prostate cancer predictive tools.
Cancer. 2008 Dec 1;113(11):3075-99. doi: 10.1002/cncr.23908.
Comment in: Cooperberg MR, Prostate cancer risk assessment: choosing the sharpest tool in the shed. [Cancer, 2008 Dec 1]
Source | Abstract | Full text | Similar articles




Stephenson AJ.
Re: Zhao et al.: External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment Score (Urology 2008;72:396-400).
Urology. 2008 Sep;72(3):719-20. doi: 10.1016/j.urology.2008.01.039.
Comment on: Zhao et al.: External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment Score (Urology 2008;72:396-400)
Source | Abstract | Full text | Similar articles




Ying J, Wang CJ, Yan J, Liauw SL, Straka C, Pistenmaa D, Xie XJ, Lotan Y, Roehrborn C, Kim DN.
Long-term Outcome of Prostate Cancer Patients Who Exhibit Biochemical Failure Despite Salvage Radiation Therapy After Radical Prostatectomy.
Am J Clin Oncol. 2015 Jul 9. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Zhao KH, Hernandez DJ, Han M, Humphreys EB, Mangold LA, Partin AW.
External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment score.
Urology. 2008 Aug;72(2):396-400. doi: 10.1016/j.urology.2007.11.165. Epub 2008 Apr 18.
Comment in: Stephenson AJ, Re: Zhao et al.: External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment Score (Urology. 2008 Sep;72(3):719-20)
Source | Abstract | Full text | Similar articles





TREATMENT



Morlacco A, Cheville JC, Rangel LJ, Gearman DJ, Jeffrey Karnes R.
Adverse Disease Features in Gleason Score 3 + 4 "Favorable Intermediate-Risk" Prostate Cancer: Implications for Active Surveillance.
Eur Urol. 2016 Aug 28. pii: S0302-2838(16)30511-5. doi: 10.1016/j.eururo.2016.08.043. [Epub ahead of print]
Source | Abstract | Full text | Similar articles